Associated Papers
Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru.
Jaramillo-Valverde L et al.
Frontiers in Bioscience (scholar Edition), 2025
Clinical Impact of CTLA-4 Single-Nucleotide Polymorphism in DLBCL Patients Treated with CAR-T Cell Therapy.
Seipel K et al.
Current Oncology (toronto, Ont.), 2025
Human iPSC-based breast cancer model identifies S100P-dependent cancer stemness induced by BRCA1 mutation.
Liu J et al.
Science Advances, 2025
Efficacy of CLT4A variants as immunoregulatory molecules among Vitiligo patients in Saudi Arabia.
Alshammary AF et al.
Scientific Reports, 2025
Epidermal second-hit mutation in MVK gene associated with linear porokeratosis.
Zhao A et al.
Genes & Diseases, 2025
Efficacy of immunotherapy in ARID1A-mutant solid tumors: a single-center retrospective study.
Zhou H et al.
Discover Oncology, 2024
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.
Vanni I et al.
Journal of Translational Medicine, 2024
Efficacy of abatacept treatment in a patient with enteropathy carrying a variant of unsignificance in CTLA4 gene: A case report.
Musabak U et al.
World Journal of Clinical Cases, 2023
Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.
Al-Harbi N et al.
Genes, 2023
Anti-Thymocyte Globulin (ATG)-Free Nonmyeloablative Haploidentical PBSCT Plus Post-Transplantation Cyclophosphamide Is a Safe and Efficient Treatment Approach for Pediatric Acquired Aplastic Anemia.
Chen RL et al.
International Journal of Molecular Sciences, 2022
Genetic susceptibility of bladder cancer in the Lebanese population.
Kourie HR et al.
Bmc Medical Genomics, 2022
Association of Cytotoxic T-Lymphocyte Antigen-4 Gene Polymorphism with Type 1 Diabetes Mellitus: In silico Analysis of Biological Features of CTLA-4 Protein on Ethiopian Population.
Ebrahim E et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy, 2022
Case report: Whole-exome sequencing identifies a novel DES mutation (p. E434K) in a Chinese family with cardiomyopathy and sudden cardiac death.
Liu YX et al.
Frontiers in Cardiovascular Medicine, 2022
Case report: Two unique nonsense mutations in HTRA1-related cerebral small vessel disease in a Chinese population and literature review.
Chen W et al.
Frontiers in Neurology, 2022
Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case-Control Study.
Ismail NA et al.
Immunological Investigations, 2021
Characterization of Rheumatoid Arthritis Risk-Associated SNPs and Identification of Novel Therapeutic Sites Using an In-Silico Approach.
Akhtar M et al.
Biology, 2021
Analysis of Relationships between Immune Checkpoint and Methylase Gene Polymorphisms and Outcomes after Unrelated Bone Marrow Transplantation.
Takahashi H et al.
Cancers, 2021
De-coding genetic risk variants in type 1 diabetes.
Shapiro MR et al.
Immunology and Cell Biology, 2021
CTLA-4 (+49A/G) Polymorphism in Type 1 Diabetes Children of Sudanese Population.
Khalid Kheiralla KE
Global Medical Genetics, 2021
Prioritization of candidate genes for a South African family with Parkinson's disease using in-silico tools.
Sebate B et al.
Plos One, 2021
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.
Hescheler DA et al.
Frontiers in Endocrinology, 2021
Genetic Variants Assessing Crohn's Disease Pattern in Pediatric Inflammatory Bowel Disease Patients by a Clinical Exome Survey.
Noel DD et al.
Bioinformatics and Biology Insights, 2021
A Novel Mutation in the IL6R Gene Identified in a Family with Asthma Patients.
Trueb B et al.
Genetic Testing and Molecular Biomarkers, 2020
Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity.
Hartman ML et al.
Cells, 2020
Introducing the first whole genomes of nationals from the United Arab Emirates.
AlSafar HS et al.
Scientific Reports, 2019
Silencing of Aberrant Secretory Protein Expression by Disease-Associated Mutations.
Tikhonova EB et al.
Journal of Molecular Biology, 2019
Analysis of error profiles in deep next-generation sequencing data.
Ma X et al.
Genome Biology, 2019
What did we learn from CTLA-4 insufficiency on the human immune system?
Mitsuiki N et al.
Immunological Reviews, 2019
Genetic association of CTLA4 gene with polycystic ovary syndrome in the Chinese Han population.
Su J et al.
Medicine, 2018
The Influence of Type 1 Diabetes Genetic Susceptibility Regions, Age, Sex, and Family History on the Progression From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study Report.
Krischer JP et al.
Diabetes, 2017
Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.
Lonjou C et al.
Bmc Cancer, 2017
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family.
De Summa S et al.
Oncotarget, 2017
A genome-wide association study identifies six novel risk loci for primary biliary cholangitis.
Qiu F et al.
Nature Communications, 2017
The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response.
Pinto R et al.
Oncotarget, 2016
Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients.
Guo Y et al.
Oncotarget, 2016
Association of CTLA4 exon-1 polymorphism with the tumor necrosis factor-α in the risk of systemic lupus erythematosus among South Indians.
Katkam SK et al.
Human Immunology, 2016
Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers.
Steck AK et al.
Pediatric Diabetes, 2014
CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.
Sun L et al.
Plos One, 2014
Targeted NGS: A Cost-Effective Approach to Molecular Diagnosis of PIDs.
Stoddard JL et al.
Frontiers in Immunology, 2014
Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case-control association study in the Italian population.
Megiorni F et al.
Archives of Dermatological Research, 2013